Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-01-19

Clinical Trial Update: Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing olanzapine, tetrabenazine, and tiapride for Huntington disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tetrabenazine (tetrabenazine)
  • olanzapine (olanzapine)
  • tiapride (tiapride)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED